Drugs / glyceryl trierucate

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT02233257 X-linked cerebral adrenoleukodystrophy University of Minnesota No longer available No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT00004450 Background Aug 1998 → Nov 2000 adrenoleukodystrophy FDA Office of Orphan Products Development Completed No outcome recorded

Evidence & citations 10 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as glyceryl trierucate ClinicalTrials.gov intervention name — accepted as the source's own label NCT00004450
Known as 13-docosenoin, tri-, (z,z,z)- ChEMBL registry synonym — accepted as the source's own label CHEMBL4297655
Known as Erucic acid triglyceride ChEMBL registry synonym — accepted as the source's own label CHEMBL4297655
Known as Glycerol trierucate ChEMBL registry synonym — accepted as the source's own label CHEMBL4297655
Known as Glyceryl trierucate component of lorenzo's oil ChEMBL registry synonym — accepted as the source's own label CHEMBL4297655
Known as Lorenzo's Oil ClinicalTrials.gov intervention name — accepted as the source's own label NCT02233257
Known as Tri(z-13-docosenoyl)glycerol ChEMBL registry synonym — accepted as the source's own label CHEMBL4297655
Known as Trierucin ChEMBL registry synonym — accepted as the source's own label CHEMBL4297655
Modality Small molecule CHEMBL4297655
Route Oral Oral use of Lorenzo's oil” NCT02233257